An OMICs-based meta-analysis to support infection state stratification

Author:

Myall Ashleigh C12,Perkins Simon1,Rushton David3,David Jonathan4,Spencer Phillippa5,Jones Andrew R1,Antczak Philipp16ORCID

Affiliation:

1. Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L697ZB, UK

2. Department of Mathematics, Imperial College London, London SW7 2AZ, UK

3. Defence and Security Analysis Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK

4. Chemical, Biological and Radiological Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK

5. Cyber and Information Systems Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK

6. Center for Molecular Medicine Cologne, University of Cologne, Cologne 50931, Germany

Abstract

Abstract Motivation A fundamental problem for disease treatment is that while antibiotics are a powerful counter to bacteria, they are ineffective against viruses. Often, bacterial and viral infections are confused due to their similar symptoms and lack of rapid diagnostics. With many clinicians relying primarily on symptoms for diagnosis, overuse and misuse of modern antibiotics are rife, contributing to the growing pool of antibiotic resistance. To ensure an individual receives optimal treatment given their disease state and to reduce over-prescription of antibiotics, the host response can in theory be measured quickly to distinguish between the two states. To establish a predictive biomarker panel of disease state (viral/bacterial/no-infection), we conducted a meta-analysis of human blood infection studies using machine learning. Results We focused on publicly available gene expression data from two widely used platforms, Affymetrix and Illumina microarrays as they represented a significant proportion of the available data. We were able to develop multi-class models with high accuracies with our best model predicting 93% of bacterial and 89% viral samples correctly. To compare the selected features in each of the different technologies, we reverse-engineered the underlying molecular regulatory network and explored the neighbourhood of the selected features. The networks highlighted that although on the gene-level the models differed, they contained genes from the same areas of the network. Specifically, this convergence was to pathways including the Type I interferon Signalling Pathway, Chemotaxis, Apoptotic Processes and Inflammatory/Innate Response. Availability Data and code are available on the Gene Expression Omnibus and github. Supplementary information Supplementary data are available at Bioinformatics online.

Funder

Chem-Bio Diagnostics program

Defense Threat Reduction Agency

Publisher

Oxford University Press (OUP)

Subject

Computational Mathematics,Computational Theory and Mathematics,Computer Science Applications,Molecular Biology,Biochemistry,Statistics and Probability

Reference61 articles.

1. On the design and analysis of gene expression studies in human populations;Akey;Nat. Genet,2007

2. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses;Andres-Terre;Immunity,2015

3. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms;Barnes;Nucleic Acids Res,2005

4. Random forests;Breiman;Mach. Learn,2001

5. On over-fitting in model selection and subsequent selection bias in performance evaluation;Cawley;J. Mach. Learn. Res,2010

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3